Jonathan Chang
Stock Analyst at Leerink Partners
(0)
# 5012
Out of 5,372 analysts
132
Total ratings
22.41%
Success rate
-28.39%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GMAB Genmab | Upgrades: Outperform | 27 | 22.05 | 22.45% | 10 | Feb 13, 2025 | |
VINC Vincerx Pharma | Maintains: Outperform | 80 40 | n/a | n/a | 6 | Oct 8, 2024 | |
IMCR Immunocore Hldgs | Initiates Coverage On: Outperform | 74 | 32.39 | 128.47% | 1 | Apr 29, 2024 | |
NBTX Nanobiotix | Initiates Coverage On: Outperform | 11 | 4.6 | 139.13% | 1 | Dec 8, 2023 | |
NVCR NovoCure | Initiates Coverage On: Outperform | 51 | 17.43 | 192.6% | 1 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 90 75 | 4.41 | 1600.68% | 12 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 9.53 | 256.77% | 9 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 18 2 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 40 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 3 2 | n/a | n/a | 7 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 50 | 7.66 | 552.74% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 30 | 39.18 | -23.43% | 4 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 12 | 1.38 | 769.57% | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 1 | n/a | n/a | 7 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 14 | n/a | n/a | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 26 | 6.16 | 322.08% | 5 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 101 95 | 37.16 | 155.65% | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 20 60 | n/a | n/a | 5 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 3 | n/a | n/a | 8 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 4 | n/a | n/a | 5 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 41 28 | 6.21 | 350.89% | 3 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 53 | 8.33 | 536.25% | 7 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 50 0 | n/a | n/a | 2 | May 10, 2018 |